Investigation of the new QNR-based mechanism of quinolone resistance among enterobacterial strains isolated in Henri-Mondor hospital 2002-2005;Émergence et diffusion chez les entérobactéries du nouveau mécanisme de résistance plasmidique aux quinolones Qnr (résultats hôpital Henri-Mondor 2002-2005)

Pathologie Biologie

Volumn 54, Issue 5, 2006, Pages 270-279

  Honore S ^a   Lascols, C ^a   Malin, D ^a   Targaouchi, R ^a   Cattoir, V ^a   Legrand, P ^a   Soussy, C J ^a   Cambau, E ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Enterobacter cloacae; ESBL; qnr; Quinolones; Resistance

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GENTAMICIN; IMIPENEM; MOXIFLOXACIN; NALIDIXIC ACID; NETILMICIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; PRIMER DNA; QUINOLINE; QUINOLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROBACTERIACEAE; GENE MUTATION; GENE SEQUENCE; GENE TRANSFER; HOSPITALIZATION; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MECHANICS; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; SCREENING; CLASSIFICATION; DRUG EFFECT; ENTEROBACTER; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; FRANCE; GENE AMPLIFICATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION;

DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FRANCE; GENE AMPLIFICATION; HUMANS; INTEGRONS; POLYMERASE CHAIN REACTION; QUINOLINES;

EID: 33746810949     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2005.11.001     Document Type: Article

References (35)

1. Hooper D.C. Bacterial topoisomerases, antitopoisomerases, and antitopoisomerase resistance. Clin. Infect. Dis. 27 Suppl 1 (1998) S54-S63
2. Hooper D.C. Mechanisms of quinolone resistance. Quinolone antimicrobial agents, 3rd Edition (2003), ASM Press, Washington, DC 41-67
3. Martinez-Martinez L., Pascual A., and Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 351 9105 (1998) 797-799
4. Tran J.H., and Jacoby G.A. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99 8 (2002) 5638-5642
5. Tran H., Jacoby G.A., and Hooper D.C. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob. Agents Chemother. 49 7 (2005) 3050-3052
6. Engelberg-Kulka H., and Glaser G. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu. Rev. Microbiol. 53 (1999) 43-70
7. Martinez-Martinez L., Pascual A., Garcia I., Tran J., and Jacoby G.A. Interaction of plasmid and host quinolone resistance. J. Antimicrob. Chemother. 51 4 (2003) 1037-1039
8. Wang M., Sahm D.F., Jacoby G.A., Zhang Y., and Hooper D.C. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob. Agents Chemother. 48 4 (2004) 1400-1401
9. Jacoby G.A., Chow N., and Waites K.B. Prevalence of plasmid-mediated quinolone resistance. Antimicrob. Agents Chemother. 47 2 (2003) 559-562
10. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., and Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47 7 (2003) 2242-2248
11. Wang M., SaHm D.F., Jacoby G.A., and Hooper D.C. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48 4 (2004) 1295-1299
12. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., and Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49 1 (2005) 71-76
13. Jeong J.Y., Yoon H.J., Kim E.S., Lee Y., Choi S.H., Kim N.J., et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob. Agents Chemother. 49 6 (2005) 2522-2524
14. Jonas D., Biehler K., Hartung D., Spitzmuller B., and Daschner F.D. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob. Agents Chemother. 49 2 (2005) 773-775
15. Poirel L., Van de Loo M., Mammeri H., and Nordmann P. Association of plasmid-mediated quinolones resistance with extended-spectrum betalactamase. Antimicrob. Agents Chemother. 49 7 (2005) 3091-3094
16. Robicsek A., Sahm D.F., Strahilevitz J., Jacoby G.A., and Hooper D.C. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob. Agents Chemother. 49 7 (2005) 3001-3003
17. Cornaglia G., Hryniewicz W., Jarlier V., Kahlmeter G., Mittermayer H., Stratchounski L., et al. on behalf of the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). European recommendations for antimicrobial resistance surveillance. Clin. Microbiol. Infect. 10 4 (2004) 349-383
18. Jarlier V., Nicolas M.H., Fournier G., and Philippon A. Extended broad-spectrum betalactamases conferring transferable resistance to newer betalactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10 4 (1988) 867-878
19. Naas T., Benaoudia F., Massuard S., and Nordmann P. Integron-located VEB-1 extended spectrum betalactamase gene in Proteus mirabilis clinical isolate from Vietnam. J. Antimicrob. Chemother. 46 5 (2000) 703-711
20. Bradford P.A. Extended-spectrum betalactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 4 (2001) 933-951
21. Chabbert Y.A., and Derlot E. Comparative activity of cefotetan on Escherichia coli K12 possessing plasmid-mediated betalactamases. J. Antimicrob. Chemother. 11 Suppl (January 1983) 159-167
22. Versalovic J., Koeuth T., and LuPski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 19 24 (1991) 682-687
23. Struelens M.J., Carlier E., Maes N., Serruys E., Quint W.G., and van Belkum A. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting. J. Hosp. Infect. 25 1 (1993) 15-32
24. Machado E., Canton R., Baquero F., Galan J.C., Rollan A., Peixe L., et al. Integron content of extended-spectrum-betalactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob. Agents Chemother. 49 5 (2005) 1823-1829
25. Nazic H., Poirel L., and Nordmann P. Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob. Agents Chemother. 49 5 (2005) 2146-2147
26. Nuesch-Inderbinen M.T., Kayser F.H., and Hachler H. Survey and molecular genetics of SHV betalactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother. 41 5 (1997) 943-949
27. Schlesinger J., Navon-Venezia S., Chmelnitsky I., Hammer-Munz O., Leavitt A., Gold H.S., et al. Extended-spectrum betalactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49 3 (2005) 1150-1156
28. Branger C., Zamfir O., Geoffroy S., Laurans G., Arlet G., Thien H.V., et al. Genetic background of Escherichia coli and extended-spectrum betalactamase type. Emerg. Infect. Dis. 11 1 (2005) 54-61
29. Conseil supérieur d'hygiène publique de France. 100 recommandations pour la surveillance et la prévention des infections nosocomiales. Bulletin épidémiologique hebdomadaire juin 1992.
30. Cambau E. Contrôler ou ne pas contrôler les épidémies hospitalières à bêtalactamase à spectre étendu (BLSE) ?. Rev. Geriatr. 8 (2003) 627-628
31. Hata M., Suzuki M., Matsumoto M., Takahashi M., Sato K., Ibe S., et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49 2 (2005) 801-803
32. Jacoby GA, Walsh K, Mills D, Walker W, Robicsek A, Oh H, Hooper DC. A new plasmid-mediated gene for quinolone resistance. In: Abstracts of the forty-fourth Interscience Conference on Antimicrobial Agents and Chemotherapy Washington, 2004. Abstract C2-1898a. American Society for Microbiology, Washington, DC, USA.
33. Genbank DQ151889. In: Cambau E, Robert J, Lascols C, Sougakoff W, Renard M., Honoré S., Bebear C., Cavallo J.D., Ploy M.C, Gutmann . L., Sirot J., Jarlier V., Soussy CJ. Emergence of distinct QNR-based mechanisms of quinolone resistance in several enterobacterial species and spread in strains producing extended-spectrum betalactamase in French hospitals. En cours de soumission.
34. Saga T., Kaku M., Onodera Y., Yamachika S., Sato K., and Takase H. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli. Antimicrob. Agents Chemother. 49 5 (2005) 2144-2145
35. Poirel L., Rodriguez-Martinez J.M., Mammeri H., Liard A., and Nordmann P. Origin of plasmid-mediated quinolone resistance determinant qnrA. Antimicrob. Agents Chemother. 49 8 (2005) 3523-3525